Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy.

Bradford Wood is an Interventional Radiologist in Bethesda, Maryland. Dr. Wood is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Liver Cancer, Enlarged Prostate (BPH), Liver Embolization, and Prostatectomy.

James Gulley is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Gulley is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.

Peter Pinto is an Urologist in Bethesda, Maryland. Dr. Pinto is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

William Dahut is an Oncologist in Washington, Washington, D.c.. Dr. Dahut is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Urothelial Cancer, Bone Tumor, Prostatectomy, and Orchiectomy.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Stephen C. Greco is a radiation oncologist at Sibley Memorial Hospital and the director of the department of radiation oncology at Suburban Hospital. Dr. Greco practices out of Sibley’s Prostate Cancer Multidisciplinary Clinic in Washington, D.C. and Suburban Hospital in Bethesda, MD. Dr. Greco has an expertise in various kinds of cancer, including lung, liver, pancreatic and prostate. He has clinical interests in conformal radiation treatment techniques and prostate cancer treatment, including prostate seed implantation. Dr. Greco earned his undergraduate degree from the University of Virginia and his medical degree from Louisiana State University School of Medicine, where he also completed an internship in internal medicine. Dr. Greco completed his residency in radiation oncology at Baylor College of Medicine. Dr. Greco has been named a Top MD by Consumers’ Checkbook Magazine and was named one of the Top Doctors in the Washington D.C., Baltimore and Washington-Baltimore areas by Castle Connolly in 2012. He is a member of the American Society of Clinical Oncology. Dr. Greco has been involved with a clinical trial for “Radiation and Androgen Ablation for Prostate Cancer.” Dr. Greco was also named the 2015 Best Consulting Physician at Suburban Hospital by Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams. Make A Gift Videos 2015 Best Consulting Physician at Suburban Hospital - Stephen Greco, M.D. Dr. Greco is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Prostatectomy.

"Shannon C. O'Connor, M.D., is a medical oncologist with Suburban Hospital. She practices out of Maryland Oncology Hematology. Dr. O'Connor has expertise in hematology and medical oncology with a special focus in women's health, including breast cancer and gynecologic cancers. Dr. O'Connor earned her Master's Degree in Physiology at Georgetown University, followed by her medical degree from St. George's University School of Medicine. She completed a residency at Washington Hospital Center, as well as a fellowship in hematology and oncology. Dr. O'Connor is a member of the American Society of Clinical Oncology, the American Society of Hematology, the Montgomery County Medical Society and the American Medical Association. Selected Publications Catlett JP1, Williams SA, O'Connor SC, Krishnan J, Malkovska V. ""Primary lymphoma of bone: an institutional experience."" Leuk Lymphoma. 2008 Nov;49(11):2125-32. doi: 10.1080/10428190802404030.". Dr. O'connor is rated as an Experienced provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Paget Disease of the Breast, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Breast Cancer.

Murray Lieberman is an Urologist in Bethesda, Maryland. Dr. Lieberman is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), UPJ Obstruction, and Ureteroscopy.

Geoffrey Neuner is a Radiation Oncologist in Silver Spring, Maryland. Dr. Neuner is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Endometrial Cancer. Dr. Neuner is currently accepting new patients.

Anup Vora is an Urologist in Silver Spring, Maryland. Dr. Vora is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Urinary Tract Infection in Children, Prostatectomy, and Ureteroscopy. Dr. Vora is currently accepting new patients.

Benjamin Cohen is an Urologist in Silver Spring, Maryland. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Ureterocele, Reconstructive Urology Surgery, and Nephrectomy. Dr. Cohen is currently accepting new patients.

Nizamuddin Maruf is an Urologist in Silver Spring, Maryland. Dr. Maruf is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Epididymitis, and Ureteroscopy. Dr. Maruf is currently accepting new patients.

Brad Lerner is an Urologist in Silver Spring, Maryland. Dr. Lerner is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Prostatectomy. Dr. Lerner is currently accepting new patients.

Dr. Rosenblum is originally from Mexico City. He received his medical degree from the Anahuac University where he graduated at the top of his class. He then competed for and was awarded a urology residency position at the prestigious National Institute of Medical Sciences in Mexico. He subsequently accepted a fellowship position in urologic oncology at the University of Colorado Health Sciences Center in Denver, where he was involved in multiple research projects relating to urologic cancers–in particular, prostate cancer treatments and prostate cancer chemoprevention. Upon completing his fellowship, Dr. Rosenblum emigrated to the United States and became board eligible by completing his second urology residency at the Washington Hospital Center in Washington, D.C. He is a diplomate of the American Board of Urology. Dr. Rosenblum has been in private practice since 2005. He also volunteers as a consultant for the Montgomery County Cancer Crusade. He has a diverse urologic practice with particular interests in minimally invasive surgery for urologic cancers. Dr. Rosenblum has published multiple journal articles and meeting abstracts, and he has been an invited lecturer both here and abroad. He has received multiple awards and distinctions along the course of his career. Dr. Rosenblum is a member of the American Urological Associationand a Fellow of the American College of Surgeons. When he is not caring for patients, Dr. Rosenblum enjoys spending time with his wife, two small daughters, and his dog, Lucas. Dr. Rosenblum is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy.

Jonathan Rhee is an Urologist in Silver Spring, Maryland. Dr. Rhee is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are UPJ Obstruction, Bilateral Hydronephrosis, Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Rhee is currently accepting new patients.

Anatoly Dritschilo is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Dritschilo is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Medulloblastoma, and Embryonal Tumor with Multilayered Rosettes.

Ravi Madan is a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Madan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Chordoma, Medullary Thyroid Carcinoma, Orchiectomy, and Prostatectomy.

Syed Mahmood is a Hematologist and a Hematologist Oncology provider in Rockville, Maryland. Dr. Mahmood is rated as an Experienced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Thrombocytopenia, RUNX1 Familial Platelet Disorder, Colorectal Cancer, and Lynch Syndrome.